Register
 

DM Educate® Comprehensive Diabetes Management - 2nd Edition
Knowledge-Based Activity

Release Date: November 2, 2011
Expiration Date: November 2, 2014

Course Overview:
DM Educate® is a knowledge-based comprehensive diabetes management course that provides users a multidisciplinary foundation in the principles of diabetes management. Contributing faculty are outstanding educators and practitioners from the fields of pharmacy, nursing, medicine, behavioral psychology, nutrition, and exercise physiology.

Target Audience:
Pharmacists, Registered Nurses, Registered Dietitians and Dietetic Technicians, Registered

Accreditation Statement:
ANCC logo
Registered Nurses: This continuing nursing education activity was approved by the American Association of Diabetes Educators, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
CDR logo
Dietitians: American Association of Diabetes Educators, (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RD) and dietetic technicians, registered (DTR) will receive 35.65 continuing professional education units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.
ACPE logo
Pharmacists: The American Association of Diabetes Educators is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 35.65 contact hours (3.565 CEU's) of continuing education credit.

The approval of this educational offering by AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

DM Educate® Course Outline:
The History of Diabetes

ACPE Universal Program Number: 0069-9999-11-278-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.1 CNEs)
ANCC - This program, 2011-052, is approved 1.0 contact hours

Educational Objectives:

  1. Describe the history of insulin development.
  2. Formulate strategies to educate patients regarding daily diabetes responsibilities.

Faculty:
Nicole Johnson, MA, MPH
President, Nicole Johnson, Inc.

Definition, Diagnosis and Pathophysiology
ACPE Universal Program Number: 0069-9999-11-279-H01-P
1.5 Contact Hours (0.15 CEUs, 1.5 CPEUs, 0.15 CNEs)
ANCC - This program, 2011-053, is approved 1.5 contact hours

Educational Objectives:

  1. Discuss the differences between type 1 and type 2 diabetes in order to validate diagnosis and select appropriate drug therapy.
  2. Describe the impact of specific drugs known to adversely affect glycemic control.
  3. Recognize patient risk of diabetes based on epidemiology data.
  4. Identify the impact of diabetes on US health economics over the next ten years.
  5. Identify patients based on diagnostic criteria for diabetes.

Faculty:
Evan Sisson, PharmD, MHA, CDE
Clinical Assistant Professor, The School of Pharmacy at Virginia Commonwealth University's Medical College of Virginia (MCV) Campus.

A Comprehensive Approach to the Management of Diabetes
ACPE Universal Program Number: 0069-9999-11-280-H01-P
2.0 Contact Hours (0.20 CEUs, 2.0 CPEUs, 0.2 CNEs)
ANCC - This program, 2011-054, is approved 2.0 contact hours

Educational Objectives:

  1. Describe the relative impact of multiple cardiovascular risk factors in patients with diabetes.
  2. Explain treatment options that are available for diabetes to patients and healthcare professionals.
  3. Recognize the importance of both insulin sensitivity and insulin resistance in the pathophysiology of type 2 diabetes.
  4. Identify the roles of different oral agents and insulins in the treatment of type 2 diabetes.

Faculty:
R. Harsha Rao, MD
Professor of Medicine, University of Pittsburgh Medical Center

Insulin and Insulin Analogs
ACPE Universal Program Number: 0069-9999-11-281-H01-P
1.5 Contact Hours (0.15 CEUs, 1.5 CPEUs, 0.15 CNEs)
ANCC - This program, 2011-055, is approved 1.5 contact hours

Educational Objectives:

  1. Describe the physiologic effects of endogenous insulin.
  2. Explain the physiologic differences between the available bolus and basal insulin products.
  3. Explain factors that affect insulin absorption and clearance and the impact on insulin dosing.
  4. Discuss side effects of insulin use including hypoglycemia.
  5. Describe barriers to insulin use and methods to overcome these barriers.
  6. Explain the process for evaluating and adjusting an insulin regimen.
  7. Discuss appropriate insulin mixtures.
  8. Describe considerations with insulin storage and syringe disposal.

Faculty:
Deanne Hall, PharmD, CDE
Assistant Professor, Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy

Insulin Devices
ACPE Universal Program Number: 0069-9999-11-282-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-056, is approved 1.0 contact hours

Educational Objectives:

  1. Explain to potential patients the process to overcome barriers to insulin treatment.
  2. Describe the advantages and disadvantages of various insulin delivery strategies and assist patients in their choices.
  3. Explain to patients the proper use of the devices currently available for insulin administration.
  4. Describe to potential insulin pump candidates the advantages of the use of continuous subcutaneous insulin infusion.

Faculty:
James Bennett, RPh, FACA, CDE
President, James Bennett Apothecary

Other Injectable Agents
ACPE Universal Program Number: 0069-9999-11-302-H01-P
2.5 Contact Hours (0.25 CEUs, 2.5 CPEUs, 0.25 CNEs)
ANCC - This program, 2011-072, is approved 2.5 contact hours

Educational Objectives:

  1. Describe neuroendocrine dysfunction and how it contributes to metabolic disturbances in diabetes mellitus.
  2. Discuss the role incretins play in the management of diabetes.
  3. Identify GLP-1 agonists in use/development and discuss their potential advantages and/or disadvantages when compared to those currently on the market.
  4. Explain the role of amylinomimetics in the treatment of diabetes.

Faculty:
Joshua Neumiller, PharmD, CDE, CGP, FASCP
Assistant Professor, Washington State University

Oral Antihyperglycemic Agents
ACPE Universal Program Number: 0069-9999-11-283-H01-P
2.0 Contact Hours (0.20 CEUs, 2.0 CPEUs, 0.20 CNEs)
ANCC - This program, 2011-057, is approved 2.0 contact hours

Educational Objectives:

  1. Describe the current American Diabetes Association/European Association for the Study of Diabetes guidelines in managing a newly diagnosed patient with type 2 diabetes mellitus.
  2. Identify pharmacologic agents available for oral administration in the treatment of type 2 diabetes and describe their classification and mechanism of action.
  3. Compare and contrast the side effect profiles of the oral agents used to treat diabetes.
  4. Evaluate and select an appropriate oral regimen for a patient with type 2 diabetes based on patient-specific data.
  5. Formulate a monitoring plan to assess efficacy and safety for a patient receiving oral antihyperglycemic agents.
  6. Counsel patients on oral antihyperglycemic agents.

Faculty:
Scott Drab, PharmD, CDE, BC-ADM
Assistant Professor, Department of Pharmacy and Therapuetics, University of Pittsburgh School of Pharmacy

Treatment of Diabetes: Pharmacotherapy (Complementary and Alternative Medicine)
ACPE Universal Program Number: 0069-9999-11-284-H01-P
1.15 Contact Hours (0.115 CEUs, 1.15 CPEUs, 0.115 CNEs)
ANCC - This program, 2011-058, is approved 1.15 contact hours

Educational Objectives:

  1. Identify complementary and alternative medicines (CAM).
  2. Describe problems that may result from CAM use.
  3. Explain commonly used CAM therapies for diabetes.
  4. Describe the pharmacology of CAM therapies in diabetes.
  5. Identify appropriate references to provide information about CAM therapies.
  6. Discuss general guidelines to patients regarding use of CAM therapies.

Faculty:
Laura Shane-McWhorter, PharmD, BCPS, FASCP, CDE, BC-ADM
Professor, University of Utah College of Pharmacy

Diabetes and Non-Prescription Products: Opportunities for Pharmacist Intervention
ACPE Universal Program Number: 0069-9999-11-286-H01-P
2.0 Contact Hours (0.20 CEUs, 2.0 CPEUs, 0.20 CNEs)
ANCC - This program, 2011-060, is approved 2.0 contact hours

Educational Objectives:

  1. Identify the pharmacist's role in managing patients with diabetes.
  2. Recommend important nonprescription products that are essential to the care of patients with diabetes.
  3. Recognize the most common obstacles or barriers to frequent, regular glucose monitoring by patients.
  4. Describe the technological advances in blood glucose monitoring that may enhance patient compliance.

Faculty:
Scott Drab, PharmD, CDE, BC-ADM
Assistant Professor, Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy

Medical Nutrition Therapy
ACPE Universal Program Number: 0069-9999-11-285-H01-P
1.5 Contact Hours (0.15 CEUs, 1.5 CPEUs, 0.15 CNEs)
ANCC - This program, 2011-059, is approved 1.5 contact hours

Educational Objectives:

  1. Discuss the role of MNT in diabetes prevention and treatment.
  2. Discuss the role of macronutrients and micronutrients in diabetes MNT.
  3. Describe MNT principles utilized in special populations such as type 1 diabetes, type 2 diabetes and pregnancy.
  4. Outline MNT strategies for special situations and to control the risk of micro and macro vascular complications.
  5. Identify diabetes meal planning, guidelines and tools for diabetes MNT that foster positive behavior change.

Faculty:
Patricia Geil, MS, RD, FADA, CDE
Owner and Nutrition Consultant, Geil Nutrition Communications

Exercise Therapy
ACPE Universal Program Number: 0069-9999-11-287-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-061, is approved 1.0 contact hours

Educational Objectives:

  1. Discuss the relative role of physical activity in body-weight regulation, i.e., energy balance.
  2. Identify the effects of exercise and dieting on body weight, body composition and metabolism.
  3. Explain physical activity and physical fitness.
  4. Identify appropriate general exercise program guidelines for type, intensity, duration and frequency of exercise.
  5. Identify behavioral strategies for starting and maintaining an exercise program.
  6. Describe the effects of exercise and insulin on blood glucose utilization.

Faculty:
Bret Goodpaster, PhD
Assistant Professor of Medicine, University of Pittsburgh Division of Endocrinology & Metabolism

Monitoring Diabetes
ACPE Universal Program Number: 0069-9999-11-600-H01-P
3.0 Contact Hours (0.30 CEUs, 3.0 CPEUs, 0.30 CNEs)
ANCC - This program, 2011-062, is approved 3.0 contact hours

Educational Objectives:

  1. Describe the roles and processes by which a healthcare provider participates in the monitoring and management of diabetes and diabetes-related conditions.
  2. Describe the various devices and tests used in the clinical monitoring and management of diabetes, as well as in the self-monitoring and management of diabetes.
  3. Describe the importance of patient information, education and counseling to effect optimal diabetes monitoring and management.

Faculty:
Margaret Yarborough, PharmD, BC-ADM, CDE
Pharmacist Clinician – Diabetes Pharmacotherapy

Complications
ACPE Universal Program Number: 0069-9999-11-288-H01-P
2.5 Contact Hours (0.25 CEUs, 2.5 CPEUs, 0.25 CNEs)
ANCC - This program, 2011-063, is approved 2.5 contact hours

Educational Objectives:

  1. Describe at least 4 physiological mechanisms by which excess glucose causes chronic complications of diabetes.
  2. List at least 4 of the major complications of diabetes.
  3. Explain the difference between non-proliferative and proliferative diabetic retinopathy.
  4. Discuss at least 6 medications that are commonly used to treat or prevent the microvascular or macrovascular complications of diabetes.

Faculty:
R. Keith Campbell, PharmD, MBA
Distinguished Professor of Pharmacy, Washington State University

Special Populations (Children and Adolescents)
ACPE Universal Program Number: 0069-9999-11-294-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-064, is approved 1.0 contact hours

Educational Objectives:

  1. Compare and contrast therapeutic regimens for children and adolescents who have Type 1 and Type 2 diabetes.
  2. Describe issues of diabetes management in schools and recommend strategies for addressing those issues.
  3. List preventive health measures that will assist in the prevention of future morbidity in children and teens with diabetes.

Faculty:
Jean Betschart-Roemer, MN, MSN, CRNP, CDE
Pediatric Nurse Practitioner, University of Pittsburgh Medical Center (Children's Hospital)

Special Populations (Older Adults)
ACPE Universal Program Number: 0069-9999-11-295-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-065, is approved 1.0 contact hours

Educational Objectives:

  1. Identify factors affected in the aging process.
  2. Discuss treatment options in management of diabetes.
  3. Discuss the effect of residence in the care of older patients.
  4. Identify common complications of diabetes in this population.

Faculty:
Susan Cornell, PharmD, CDE
Assistant Professor of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy

Special Populations (Preconception and Pregnancy)
ACPE Universal Program Number: 0069-9999-11-296-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-066, is approved 1.0 contact hours

Educational Objectives:

  1. Explain the differences in classification of diabetes during pregnancy.
  2. Identify goals in monitoring parameters.
  3. Compare and contrast the pharmacologic and nonpharmacologic treatment strategies used during pregnancy.
  4. Discuss the components of diabetes self-management in pregnancy.

Faculty:
Susan Cornell, PharmD, CDE
Assistant Professor of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy

Psychological Issues
ACPE Universal Program Number: 0069-9999-11-297-H01-P
2.25 Contact Hours (0.225 CEUs, 2.25 CPEUs, 0.225 CNEs)
ANCC - This program, 2011-067, is approved 2.25 contact hours

Educational Objectives:

  1. Discuss the scope of problematic diabetes self-management behaviors in the American population.
  2. Identify major health issues that influence diabetes self care.
  3. Discuss why self care plans are often unachievable.

Faculty:
William Polonsky, PhD, CDE
President and Founder, Behavioral Diabetes Institute;
Assistant Clinical Professor in Psychiatry, University of California, San Diego

Education: Goal Setting, Lifelong Learning, Survival Skills, Visually Impaired
ACPE Universal Program Number: 0069-9999-11-298-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-068, is approved 1.0 contact hours

Educational Objectives:

  1. Explain the role of goal setting and behavior change in treating patients with diabetes.
  2. Compare and contrast adult education vs. child learners.
  3. Describe life stages.
  4. Discuss diabetes self care behavior and their application to patient management.
  5. Describe diabetes care tools for the visually impaired.

Faculty:
Linda Siminerio, RN, PhD, CDE
Executive Director, University of Pittsburgh Diabetes institute
Assistant Professor, Division of Endocrinology, University of Pittsburgh School of Medicine
Assistant Professor, University of Pittsburgh School of Nursing

Education: Empowerment, Behavior Change, Low Health Literacy, Cultural Sensitivity
ACPE Universal Program Number: 0069-9999-11-299-H01-P
1.25 Contact Hours (0.125 CEUs, 1.25 CPEUs, 0.125 CNEs)
ANCC - This program, 2011-069, is approved 1.25 contact hours

Educational Objectives:

  1. Compare and contrast education strategies to manage patients with diabetes.
  2. Describe the 5-step model of behavior change.
  3. Describe behavior change assessment models and tools used by healthcare professionals working with patients with diabetes.
  4. Select tools to assess low literacy.
  5. Define culture and cultural competence in diabetes education.

Faculty:
Robin Nwankwo, MPH, RD, CDE
Diabetes Self-Management Consultant, University of Michigan

The Pharmacist's Role in Management of the Patient with Diabetes
ACPE Universal Program Number: 0069-9999-11-300-H01-P
1.0 Contact Hours (0.10 CEUs, 1.0 CPEUs, 0.10 CNEs)
ANCC - This program, 2011-070, is approved 1.0 contact hours

Educational Objectives:

  1. Explain the state of diabetes care in the US today and how the pharmacist can impact that care.
  2. Discuss the basic framework for the pharmacist to become an integral member of the diabetes care team.
  3. Describe how to implement a successful diabetes care program.

Faculty:
Jerry Meece, RPh, FAA, CDE
Owner, Director of Clinical Services, Plaza Pharmacy and Wellness Center

Inpatient Diabetes Management
ACPE Universal Program Number: 0069-9999-11-301-H01-P
2.0 Contact Hour (0.20 CEUs, 2.0 CPEUs, 0.20 CNEs)
ANCC - This program, 2011-071, is approved 2.0 contact hours

Educational Objectives:

  1. Describe the relationship between hyperglycemia and poor outcomes in hospitalized patients.
  2. Formulate guidelines for glycemic targets in hospitalized patients.

Faculty:
Scott Drab, PharmD, CDE, BC-ADM
Assistant Professor, Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy

Amy Calabrese Donihi, PharmD, BCPS
Assistant Professor, Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy

Cultural Competence: Hispanic/Latino Patients with Diabetes
ACPE Universal Program Number: 0069-9999-11-303-H01-P
2.5 Contact Hours (0.25 CEUs, 2.5 CPEUs, 0.25 CNEs)
ANCC - This program, 2011-073, is approved 2.5 contact hours

Educational Objectives:

  1. Describe rationale for the development of cultural competence in pharmacy practice.
  2. Discuss DM disease state prevalence and incidence among the Hispanic population.
  3. Identify how cultural related barriers may impact DM management.
  4. Discuss the importance of working with trained interpreters and how to use interpreters effectively.
  5. Formulate a treatment plan in collaboration with the patient, their family, and all members of health care team.

Faculty:
Gladys Garcia, PharmD
Assistant Professor of Clinical Pharmacy, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia

Francisco Javier Jimenez, RPh, PharmD, BCPS, CDE
Associate Professor, University of Puerto Rico School of Pharmacy
Clinical Pharmacist, Farmacia San Jose, Puerto Rico

Krista Salazar, PharmD, PhC
Assistant Professor, Pharmacy Clinician Educator, University of New Mexico

DISCLOSURE DECLARATION
In compliance with the American Association of Diabetes Educators and their credentialing bodies we would like to identify the following financial relationship(s) of faculty providing content for this course:

Instructions for Receiving Credit:
To receive the credit for each section you must:

  • Review the program
  • Successfully complete the post-test (70% or higher) within 2 attempts

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation.

Commercial Support:
This program is supported by an educational grant from Novo Nordisk, Inc.

Software Requirements:

PC
Internet Explorer (v7 or greater), or Firefox (Latest Version)
Windows XP or greater
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution
(1024 x 768 Recommended)
Flash Player Plugin (9.0 or later) | Check your version here
Silverlight Plugin
Adobe Acrobat Reader*



MAC
MAC OS 10.4
Firefox (Latest Version)
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution
(1024 x 768 Recommended)
Flash Player Plugin (9.0 or later) | Check your version here
Silverlight Plugin
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.

* Required to view printable (PDF) version of the lesson.


Select a Profession to Continue:

For our Terms of Use and Privacy Policy please review our Legal Agreement.
Copyright© CECity.com, Inc., CECity® and CentricitySM are registered trademarks of CECity.com, Inc. All rights reserved.